Stocktitan

Published October 8, 2026 · Updated October 9, 2026

Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand

Read the full story at Stocktitan

The agreement follows Medsafe's 4 September 2026 approval of two psychiatrists to prescribe MDMA for post-traumatic stress disorder (PTSD). Rua will.